Discussing Rheumatology: Baricitinib and Itacitinib

Prof Iain McInnes discusses the use of baricitinib to treat COVID-19 and a JAK inhibitor, itacitinib. Keep up-to-date with the latest information in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.